PA1, known formally as PTIP associated 1, is involved in the molecular processes of histone H3-K4 methylation. As a component of the MLL3/4 complex, it plays a significant role in the regulation of chromatin structure and subsequent gene expression. The modulation of histone methylation by PA1 holds implications in diverse cellular functions, ranging from transcriptional activity to DNA repair mechanisms. This protein is evolutionarily conserved and has orthologs in several organisms, emphasizing its fundamental role in cellular machinery.
The class of inhibitors targeting PA1 predominantly functions by influencing the histone methylation pathways. While direct inhibition of PA1 is less explored, the broader chemical compounds in this category often target associated proteins or enzymatic activities that indirectly modulate PA1 function. These inhibitors usually work by disrupting protein-protein interactions, inhibiting enzymatic methyltransferase activities, or altering binding affinities between associated components. The result is a change in the histone methylation landscape, which can lead to diverse cellular outcomes depending on the specific context and environment. As chromatin structure and histone modification are critical for numerous cellular processes, inhibitors in this category can have profound effects on cellular function and behavior. By understanding the intricate web of interactions and functions related to PA1, these chemical compounds provide a means to probe and dissect the underlying mechanisms of histone methylation and chromatin remodeling.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
A flavonoid known to inhibit a range of kinases. It might influence histone methylation indirectly. By inhibiting enzymes involved in histone methylation, Quercetin could potentially affect PA1's associated activity in the MLL3/4 complex. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
Primarily inhibits G9a histone methyltransferase. This chemical might alter the histone methylation landscape and indirectly impact pathways that PA1 is involved in. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
A G9a and GLP histone methyltransferase inhibitor. It may affect methylation at other histone sites indirectly and therefore have an influence on the function of PA1. | ||||||
Epz004777 | 1338466-77-5 | sc-507560 | 100 mg | $575.00 | ||
Direct inhibitor of DOT1L, a H3K79 methyltransferase. Changes in H3K79 methylation could indirectly influence the activity or function of PA1. | ||||||
3-[(3-Methoxybenzoyl)amino]-4-(4-methyl-1-piperazinyl)benzoic acid methyl ester-d3 | 890190-22-4 (unlabeled) | sc-484812 | 1 mg | $380.00 | ||
It disrupts the interaction between MLL1 and WDR5, a component of the MLL complex. This might impact the MLL3/4 complex and therefore PA1's function. | ||||||
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $126.00 | 5 | |
It inhibits SUV39H1, a histone methyltransferase. Although it targets a different methylation site, it may influence the broader histone methylation environment, which could indirectly affect PA1. | ||||||
9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-β-D-ribofuranosyl]-9H-purin-6-amine | 1380288-87-8 | sc-500607 | 50 mg | $13500.00 | ||
A DOT1L inhibitor. By targeting H3K79 methylation, it might indirectly influence pathways that PA1 is involved in. | ||||||
A-366 | 1527503-11-2 | sc-507495 | 10 mg | $195.00 | ||
It's an inhibitor of G9a and GLP histone methyltransferase. May influence methylation at other histone sites and therefore affect the function of PA1. | ||||||